BIOLIFE SOLUTIONS INC (BLFS)
Health Care · Biopreservation and cell processing for cell and gene therapy · NASDAQ
BioLife Solutions develops biopreservation media and cell processing products designed to improve quality and reduce risk in cell and gene therapy manufacturing and distribution.
What BIOLIFE SOLUTIONS INC does
BioLife Solutions is a life sciences company that develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry. The company's portfolio focuses on biopreservation media and cell processing products that help customers maintain the health and function of biologic material during sourcing, manufacturing, and distribution. The company leverages in-house expertise in cryobiology and broader CGT workflows to support multiple steps in biologic material manufacturing and delivery. Recent strategic moves include the acquisition of PanTHERA's Ice Recrystallization Inhibitor technology and the divestiture of non-core businesses (SAVSU, CBS, SciSafe, Global Cooling) to focus on core biopreservation capabilities.
Themes: ["Cell and gene therapy (CGT)","Biopreservation","Biologic manufacturing","Cryopreservation technology","Regenerative medicine supply chain"]
Fundamentals
- Price$28.23 as of 2026-07-09 close
- Market cap$1.3B as of 2026-07-10
- 1-year return+26.4% as of 2026-07-09 close
- Net margin-3.0% as of 2026-07-10
- Gross margin+64.0% as of 2026-07-10
- ROE-0.8% as of 2026-07-10
- Debt / equity0.01 as of 2026-07-10
- Revenue growth (YoY)+25.6% as of 2026-07-10
- Revenue CAGR (3y)+30.9% SEC XBRL
- Beta1.92 as of 2026-07-10
Key risks (from latest filing)
["Dependence on cell and gene therapy market adoption and regulatory approval timelines, which are inherently uncertain and subject to long development cycles","Integration risk and potential impairment of goodwill ($208.6M) and intangible assets related to acquisitions such as PanTHERA","Company remains unprofitable with -2.97% net margin; recent profitability is dependent on interest income and other gains, not core operations"]
Competitors & peers
- Thermo Fisher Scientific
- Lonza Group
- Corning Incorporated
- FUJIFILM Cellular Dynamics
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.